Voraruth C, Pirojsakul K, Saisawat P, Chantarogh S, Tangnararatchakit K. Clinical outcomes of renal replacement therapy in pediatric acute kidney injury: a 10-year retrospective observational study. Glob Pediatr Health. 2022;9:2333794X2211424.

Google Scholar 

Cortina G, McRae R, Hoq M, Donath S, Chiletti R, Arvandi M, Gothe RM, Joannidis M, Butt W. Mortality of critically ill children requiring continuous renal replacement therapy: effect of fluid overload, underlying disease, and timing of initiation*. Pediatr Crit Care Med. 2019;20(4):314–22.

Article  PubMed  Google Scholar 

Novy E, Martinière H, Roger C. The current status and future perspectives of beta-lactam therapeutic drug monitoring in critically ill patients. Antibiotics. 2023;12(4):681.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Okamoto MP, Nakahiro RK, Chin A, Bedikian A. Cefepime clinical pharmacokinetics. Clin Pharmacokinet. 1993;25(2):88–102.

Article  CAS  PubMed  Google Scholar 

Tam VH, McKinnon PS, Akins RL, Rybak MJ, Drusano GL. Pharmacodynamics of cefepime in patients with Gram-negative infections. J Antimicrob Chemother. 2002;50(3):425–8.

Article  CAS  PubMed  Google Scholar 

Honore PM, Spapen HD. What a clinician should know about a renal replacement membrane? J Transl Int Med. 2018;6(2):62–5.

Article  PubMed  PubMed Central  Google Scholar 

Roger C, Louart B. Beta-lactams toxicity in the intensive care unit: an underestimated collateral damage? Microorganisms. 2021;9(7):1505.

Article  PubMed  PubMed Central  Google Scholar 

Payne LE, Gagnon DJ, Riker RR, Seder DB, Glisic EK, Morris JG, Fraser GL. Cefepime-induced neurotoxicity: a systematic review. Crit Care. 2017;21(1):276.

Article  PubMed  PubMed Central  Google Scholar 

Hambrick HR, Pavia K, Tang Girdwood S, Lazear D, Taylor JM, Benoit S. Cefepime-associated neurotoxicity in a pediatric patient with stage V chronic kidney disease. J Pharm Pract. 2024;37(1):243–7.

Article  PubMed  Google Scholar 

Miano TA, Hennessy S, Yang W, Dunn TG, Weisman AR, Oniyide O, Agyekum RS, Turner AP, Ittner CAG, Anderson BJ, Wilson FP, Townsend R, Reilly JP, Giannini HM, Cosgriff CV, Jones TK, Meyer NJ, Shashaty MGS. Association of vancomycin plus piperacillin–tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study. Intensive Care Med. 2022;48(9):1144–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bauer SR, Salem C, Connor MJ, Groszek J, Taylor ME, Wei P, Tolwani AJ, Fissell WH. Pharmacokinetics and pharmacodynamics of piperacillin-tazobactam in 42 patients treated with concomitant CRRT. Clin J Am Soc Nephrol. 2012;7(3):452–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stitt G, Morris J, Schmees L, Angelo J, Akcan AA. Cefepime pharmacokinetics in critically ill pediatric patients receiving continuous renal replacement therapy. Antimicrob Agents Chemother. 2019;63(4):10–1128.

Article  Google Scholar 

Pavia K, Hambrick HR, Paice K, Tang P, Punt N, Kaplan J, Goldstein SL, Vinks AA, Mizuno T, Tang GS. Cefepime pharmacokinetics in critically ill children and young adults undergoing continuous kidney replacement therapy. J Antimicrob Chemother. 2023;78(9):2140–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stitt G, Dubinsky S, Edginton A, Huang YSV, Zuppa AF, Watt K, Downes K. Antimicrobial dosing recommendations in pediatric continuous renal replacement therapy: a critical appraisal of current evidence. Front Pediatr. 2022;10: 889958.

Article  PubMed  PubMed Central  Google Scholar 

McKnite AM, Green DJ, Nelson R, Brewer SC, Watt KM. Medication patterns and dosing guidance in pediatric patients supported with intermittent hemodialysis or continuous kidney replacement therapy. Pediatr Nephrol. 2024;39(5):1521–32.

Article  PubMed  Google Scholar 

Drusano GL. Antimicrobial pharmacodynamics: critical interactions of “bug and drug.” Nat Rev Microbiol. 2004;2(4):289–300.

Article  CAS  PubMed  Google Scholar 

Selewski DT, Barhight MF, Bjornstad EC, Ricci Z, de Sousa TM, Akcan-Arikan A, Goldstein SL, Basu R, Bagshaw SM, Alobaidi R, Askenazi DJ, Barreto E, Bayrakci B, Bignall ONR, Brophy P, Charlton J, Chanchlani R, Conroy AL, Deep A, Devarajan P, Dolan K, Fuhrman D, Gist KM, Gorga SM, Greenberg JH, Hasson D, Heydari E, Iyengar A, Jetton J, Krawczeski C, Meigs L, Menon S, Morgan C, Morgan J, Mottes T, Neumayr T, Soranno D, Stanski N, Starr M, Sutherland SM, Symons J, Vega M, Zappitelli M, Ronco C, Mehta RL, Kellum J, Ostermann M. Fluid assessment, fluid balance, and fluid overload in sick children: a report from the Pediatric Acute Disease Quality Initiative (ADQI) conference. Pediatr Nephrol. 2024;39(3):955–79.

Article  PubMed  Google Scholar 

Sutherland SM, Goldstein SL, Alexander SR. The prospective pediatric continuous renal replacement therapy (ppCRRT) registry: a critical appraisal. Pediatr Nephrol. 2014;29(11):2069–76.

Article  PubMed  Google Scholar 

Morales R, Mizuno T, Paice KM, Hambrick HR, Punt N, Tang GS. Impact of fluid balance on beta-lactam antibiotics target attainment: insights from a simulation-based meropenem study. Int J Antimicrob Agents. 2024;64(3): 107267.

Article  CAS  PubMed  Google Scholar 

Rozenveld E, Punt N, van Faassen M, van Beek AP, Touw DJ. Pharmacokinetic modeling of hydrocortisone by including protein binding to corticosteroid-binding globulin. Pharmaceutics. 2022;14(6):1161.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abolhassani-Chimeh R, Akkerman OW, Saktiawati AMI, Punt NC, Bolhuis MS, Subronto YW, Sumardi, van der Werf TS, Kosterink JGW, Alffenaar JWC, Sturkenboom MGG. Population pharmacokinetic modelling and limited sampling strategies for therapeutic drug monitoring of pyrazinamide in patients with tuberculosis. Antimicrob Agents Chemother. 2022;66(7):e00003.

Article  PubMed  PubMed Central  Google Scholar 

van den Born DA, Märtson AG, Veringa A, Punt NC, van der Werf TS, Alffenaar JWC, Sturkenboom MGG, Touw DJ. Voriconazole exposure is influenced by inflammation: a population pharmacokinetic model. Int J Antimicrob Agents. 2023;61(4): 106750.

Article  PubMed  Google Scholar 

Nehus EJ, Mouksassi S, Vinks AA, Goldstein S. Meropenem in children receiving continuous renal replacement therapy: clinical trial simulations using realistic covariates. J Clin Pharmacol. 2014;54(12):1421–8.

Article  CAS  PubMed  Google Scholar 

Robatel C, Decosterd LA, Biollaz J, Eckert P, Schaller MD, Buclin T. Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients. J Clin Pharmacol. 2003;43(12):1329–40.

Article  CAS  PubMed  Google Scholar 

Philpott CD, Droege CA, Droege ME, Healy DP, Courter JD, Ernst NE, Harger NJ, Foertsch MJ, Winter JB, Carter KE, Van Fleet SL, Athota K, Mueller EW. Pharmacokinetics and pharmacodynamics of extended-infusion cefepime in critically ill patients receiving continuous renal replacement therapy: a prospective, open-label study. Pharmacother J Human Pharmacol Drug Ther. 2019;39(11):1066–76.

Article  CAS  Google Scholar 

Shoji K, Bradley JS, Reed MD, van den Anker JN, Domonoske C, Capparelli EV. Population pharmacokinetic assessment and pharmacodynamic implications of pediatric cefepime dosing for susceptible-dose-dependent organisms. Antimicrob Agents Chemother. 2016;60(4):2150–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20(3):629–37.

Article  PubMed  PubMed Central  Google Scholar 

John JC, Taha S, Bunchman TE. Basics of continuous renal replacement therapy in pediatrics. Kidney Res Clin Pract. 2019;38(4):455–61.

Article  PubMed  PubMed Central  Google Scholar 

Spinale JM, Laskin BL, Sondheimer N, Swartz SJ, Goldstein SL. High-dose continuous renal replacement therapy for neonatal hyperammonemia. Pediatr Nephrol. 2013;28(6):983–6.

Article  PubMed  PubMed Central  Google Scholar 

CLSI. Performance Standards for Antimicrobial Susceptibility Testing; 2023. https://clsi.org/standards/products/microbiology/documents/m100/